EMERGENCY COVID-19 TREATMENT APPROVED
FDA Okays Gilead's Remdesivir Drug Source: Gilead Sciences Remdesivir Good News in COVID-19 Fight Finally, some good news to report on the war against COVID-19. The US Food and Drug Administration has given emergency approval to Gilead Sciences' remdesivir drug to treat patients with the coronavirus. President Donald Trump made the announcement. Gilead CEO Daniel O'Day promised that the company is going to donate one million vials of the drug for treating patients. Results Tell the Story The FDA emergency order means that doctors can use the drug even though it hasn't gone through the FDA's formal, time-consuming approval process. The results on this unique drug tell the story. An independent analysis by the US National Institute of Allergy & Infectious Diseases showed that COVID patients who took the drug usually recovered after 11 days. That is 4 days earlier than patients not given the drug....